Oculis Looks To Move Dry Eye Candidate To Phase III Despite Mixed Dataset

 
• By Joseph Haas
  
Dry eye disease
Oculis thinks its candidate can benefit a genetic subset of dry eye patients • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D